Monday, February 28, 2005
The CNN Health website, as well as many others, are reporting that the makers of a new multiple sclerosis drug have voluntarily pulled it from the market today after one patient died and another developed a serious disease. According to CNN,
Experts said the announcement by Biogen Idec Inc. and Elan Corp. marks sad turn of events for MS sufferers who have endured a more than centurylong search for effective treatments for the incurable disease.
The news came three months after the government approved the drug, called Tysabri. Stocks of both Massachusetts-based Biogen Idec Inc. and Ireland-based Elan Corp. tumbled on the announcement.
The companies said they will investigate the effects of the medication further, and they are not giving up hope that the drug may eventually return to the market.
I don't know what to think of the drug manufacturer's vigilence here. I don't have the data here but it seems to me that the quick reaction may be a little too quick. [bm]